PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 5, 2026Transplant International1 citationsOpen Access

Effect of Normothermic Machine Perfusion on Glycocalyx Shedding During Liver Transplantation – A Prospective Pilot Study

SMSimon MathisGPGabriel PutzerLGLukas Gasteiger

Key Points

  • This study aims to evaluate how normothermic machine perfusion affects glycocalyx integrity during liver transplantation and its correlation with early postoperative results.
  • Analyzed thirty liver grafts undergoing normothermic machine perfusion before transplantation.
  • Quantified syndecan-1 and heparan sulfate in perfusate and recipient serum.
  • Assessed donor-related factors affecting glycocalyx injury during perfusion.
  • Established correlations between glycocalyx degradation and early postoperative outcomes.
  • Syndecan-1 levels increased during normothermic machine perfusion and were higher in grafts from circulatory-death donors than brain-death donors.
  • A cut-off of 4,796.13 ng/mL for syndecan-1 indicated predictive potential for early allograft dysfunction after 6 hours of perfusion.
  • Post-transplant syndecan-1 levels in recipient serum were elevated initially but decreased over days, while heparan sulfate levels remained stable.

Abstract

Ischemia–reperfusion injury (IRI) plays a pivotal role in liver transplantation by inducing oxidative stress and inflammation, thereby contributing to impaired graft function and postoperative complications. A key element of IRI is degradation of the endothelial glycocalyx, resulting in microcirculatory dysfunction. This study investigated the impact of normothermic machine perfusion (NMP) on glycocalyx integrity and its association with early postoperative outcomes. Thirty grafts undergoing NMP prior to transplantation were analyzed. Syndecan-1 and heparan sulfate were quantified in perfusate and recipient serum. Donor-related factors influencing glycocalyx injury during NMP were assessed, and correlations with outcomes established. Syndecan-1 levels increased during NMP and remained significantly elevated in grafts from circulatory-death (DCD) donors compared with brain-death (DBD) donors. Receiver operating characteristics revealed predictive potential for early allograft dysfunction (EAD) with a syndecan-1 cut-off of 4,796.13 ng/mL after 6 h of NMP. In contrast, heparan sulfate concentrations showed no relevant changes. Postoperatively, syndecan-1 levels in recipient serum were elevated immediately after transplantation but declined over subsequent days, while heparan sulfate remained stable. These findings indicate that glycocalyx injury develops during NMP, particularly in DCD livers, with elevated syndecan-1 reflecting endothelial vulnerability and a potentially modifiable aspect of graft physiology relevant to future protective strategies. Clinical Trial Registration www.Clinicaltrials.gov , identifier NCT: 04764266.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mathis et al. (2026) studied this question.

synapsesocial.com/papers/69a91cf1d6127c7a504bfde6https://doi.org/10.3389/ti.2026.15502
Ask AI
Helpful
Bookmark
Share
View Full Paper